Boutillier A L, Kienlen-Campard P, Loeffler J P
UMR 7519 CNRS, IPCB, Strasbourg, France.
Eur J Neurosci. 1999 Feb;11(2):441-8. doi: 10.1046/j.1460-9568.1999.00451.x.
Depolarization and subsequent calcium entry exert essential neuroprotective effects but the ultimate effector by which calcium blocks apoptosis is not known. Here we show that inhibition of calcium entry into cerebellar neurons by switching from high to low extracellular K+ concentrations (30-5 mM) induces apoptosis, that correlates with a rapid accumulation of cyclin D1 (CD1), an early marker of the G1/S transition of the cell cycle. These effects on apoptosis and cyclin D1 are mimicked either by blocking calcium entry into neurons (LaCl3, 100 microM or nifedipine, 10(-6) M) or by inhibiting the calcium/calmodulin pathway (calmidazolium, 10(-7) M). The increased CD1 protein levels do not result from a transcriptional upregulation of the CD1 gene by the Ca2+/calmodulin pathway but rather reflect an accumulation due to the lack of degradation by the proteasome-dependent pathway. Specific proteasome antagonists: carbobenzoxyl-leucinyl-leucinyl-norvalinal-H (MG-115), carbobenzoxyl-leucinyl-leucinyl-leucinal-H (MG-132) and clastolactacystin beta-lactone, induce neuronal apoptosis by themselves. Finally, this pathway is functional only at neuroprotective concentrations of K+ (30 mM), suggesting that calcium/CamK signalling pathway may regulate neuronal death by regulating the proteasome-mediated degradation activity of rapidly turning-over proteins (constitutively expressed genes or pre-existing pools of mRNA).
去极化及随后的钙内流发挥着重要的神经保护作用,但钙阻止细胞凋亡的最终效应器尚不清楚。在此我们表明,通过将细胞外钾离子浓度从高(30 mM)切换到低(5 mM)来抑制钙进入小脑神经元会诱导细胞凋亡,这与细胞周期G1/S转换的早期标志物细胞周期蛋白D1(CD1)的快速积累相关。阻断钙进入神经元(100 μM 氯化镧或10⁻⁶ M硝苯地平)或抑制钙/钙调蛋白途径(10⁻⁷ M 卡米达唑)可模拟这些对细胞凋亡和细胞周期蛋白D1的影响。细胞周期蛋白D1蛋白水平的升高并非源于钙/钙调蛋白途径对细胞周期蛋白D1基因的转录上调,而是反映了由于蛋白酶体依赖性途径缺乏降解导致的积累。特异性蛋白酶体拮抗剂:苄氧羰基 - 亮氨酰 - 亮氨酰 - 正缬氨酸 - H(MG - 115)、苄氧羰基 - 亮氨酰 - 亮氨酰 - 亮氨酸 - H(MG - 132)和氯抑酶素β - 内酯,自身即可诱导神经元凋亡。最后,该途径仅在具有神经保护作用的钾离子浓度(30 mM)下发挥作用,这表明钙/CamK信号通路可能通过调节蛋白酶体介导的快速周转蛋白(组成型表达基因或预先存在的mRNA池)的降解活性来调节神经元死亡。